Key Drivers
- Heavy leverage
- Tight liquidity
- Unstable cash flow
AIAI Summary
FTRE is shifting from a distressed CRO story to a fragile turnaround where improving bookings, stable margins, and an AI-led product reset are encouraging, but the stock remains investable only if management can convert this momentum into several quarters of positive cash flow before the tight liquidity and heavy leverage become binding.
Price Chart
Financial Metrics
Deep Analysis
Research tool. Not personalized advice.
Fundamental Analysis
Key Financial Insights:
- •Heavy leverage
- •Tight liquidity
- •Unstable cash flow
FTRE remains a high-risk turnaround story: improving near-term gross profitability and positive FY2025 cash generation are offset by tight liquidity, heavy leverage, and inconsistent Q1 cash flow.
Price Behavior
Key Price Behavior Insights:
- •Rebound intact
- •Range-high hold
- •Resistance cap
FTRE's last month trend is constructive, rebounding from a mid-June low and holding near the recent highs, but it still needs a clean break above $17.71 resistance to confirm more upside.
Sharp rebound from about $15.31 on 2026-06-18 to a near $17.71 peak on 2026-06-25
Sentiment & News
Key News Insights:
- •Inducement awards
- •CFO transition
- •Team strengthening
Fortrea's June announcements highlight management reshaping, with inducement RSUs for new hires and Jason Knoblauch set to replace Jill McConnell as CFO.
This signals a modestly positive operational setup as Fortrea reinforces its leadership and talent pipeline, though it does not yet indicate any direct change in business performance
Similar Companies in Healthcare
Other companies in the same sector with AI ratings